fda tirzepatide ruling Compounders lose battle over Eli Lilly weight loss drug and shortage list FDA says shortage of GLP-1

MEDVi also outsources clinical care to OpenLoop Health, which disclosed a January 2026 data breach affecting approximately 1.6 million patient records (68,160 confirmed in Texas)

Regular follow-up allows her to monitor blood sugar, weight changes, treatment tolerance, and potential side effects while adjusting the care plan when clinically indicated

GLP-1 market volume expansion

Were not looking for the next juice cleanse or exercise fad

are less likely to use the drugs than white people, a 2024 study in the Journal of Racial and Ethnic Health Disparitie s found

Ozempic medication is not recommended for those looking only for weight loss because other options, like Wegovy, are designed for that purpose